PRE-CONFERENCE SHORT COURSES | SEPTEMBER 25, 2:00-5:00 PM

SC1: Introduction to GPCR-Based Drug Discovery
Instructor:
Annette Gilchrist, PhD, Professor, Pharmacology, Midwestern University

PRE-CONFERENCE DINNER SHORT COURSES | SEPTEMBER 25, 6:00-8:30 PM

SC7: Enabling Macrocyclic Compounds for Drug Discovery
Instructor:
Mark Peterson, PhD, COO, Cyclenium Pharma, Inc.

SC8: Targeting of Ion Channels with Monoclonal Antibodies
Instructor:
Trevor Wilkinson, PhD, Associate Director, Antibody Discovery and Protein Engineering, Medimmune Ltd., United Kingdom

DINNER SHORT COURSES | SEPTEMBER 27, 7:00-9:30 PM

SC13: GPCR Structure-Based Drug Discovery
Instructors: Matthew Eddy, PhD, Postdoctoral Fellow, Ray Stevens Laboratory, The Bridge Institute, University of Southern California
Huixian Wu, PhD, Principal Scientist, Structural and Molecular Sciences, Discovery Sciences, Pfizer, Inc. Groton

SC14: Advancing Tools and Technologies for Fragment-Based Design
Instructor:
Daniel A. Erlanson, PhD, Co-Founder, Carmot Therapeutics, Inc.

SC15: Introduction to Targeted Covalent Inhibitors
Instructor:
Mark Schnute, PhD, Associate Research Fellow, Medicine Design, Inflammation & Immunology Research, Pfizer, Inc.

SC16: Immunology Basics
Instructors:
Songqing Na, PhD, Senior Scientist, Biotechnology & Autoimmunity Res-AME, Eli Lilly and Company
Thomas Sundberg, PhD, Senior Research Scientist I, Center for Development of Therapeutics, Broad Institute of MIT and Harvard

SC17: Technologies to Assess Permeability and Efflux in Gram-Negative Bacterial Pathogens
Instructors:
David Six, PhD, Investigator III, Infectious Diseases, Novartis Institutes for BioMedical Research
Ram Iyer, PhD, Principal Scientist (Bacteriology), Entasis Therapeutics, Inc.

* Separate registration required for Short Courses